OpenEvidence vs UpToDate cost, sources and which one to use

It is genuinely free for clinicians who complete verification, which in the US means confirming your NPI. There is no paywall waiting behind the first few questions, and we break down what OpenEvidence costs and who the verification gate locks out in full. The model is advertising: pharmaceutical and other healthcare advertisers pay to reach a verified clinical audience, which is how a tool that answers millions of clinical questions a month covers its costs.

The honest caveat is not a hidden fee, it is the incentive. An ad-supported tool sits in the same page as promotional content, and clinicians differ on how comfortable they are with that. If that bothers you, a paid reference removes the question entirely. If it does not, the free access is real and worth having.

It depends on whether you value a graded, edited recommendation over a summary of the literature. UpToDate topics are written by named physician authors, reviewed, and given explicit strength-of-recommendation grades. When you are about to do something consequential and want a defensible position, that editorial layer is what you are paying for, and a literature summary is not the same thing.

Where the value gets harder to defend is speed. If your question is narrow and factual, reading a long topic review to extract one line is slow, and that is exactly the gap free answer engines moved into. Many clinicians have quietly settled on using both: the answer engine for quick questions, the paid reference when the decision is heavier. Also worth knowing before you renew: check whether your hospital or medical library already licenses it, because a great many US clinicians pay for a subscription they could access for free through their institution.

We re-read both vendors in September 2026. OpenEvidence's own site still states that it is free and unlimited for verified US healthcare professionals, lists content agreements with NEJM, JAMA and the JAMA Network, Nature Portfolio and Cochrane, and names society partners including the AAP, ACC, ACOG and ACEP. The UpToDate store still publishes no price before a country, role and login; every route in is on our UpToDate subscription page. If the reason you are reconsidering UpToDate is price rather than AI, the one full clinical reference with a public rate card is ClinicalKey, compared in ClinicalKey vs UpToDate.

Both tools answer questions you ask. Neither watches the prescription you are about to sign and tells you, unprompted, that the patient is already on a drug that interacts with it, that their renal function makes the standard dose wrong, or that a documented allergy blocks the obvious choice. To get that from a reference or an answer engine you have to know to ask, four separate times, and prescribing errors mostly happen precisely when nobody thought to ask.

That is the job Prescriber.io is built for. You enter the drug or the scenario once and it checks for drug-drug interactions, flags contraindications and allergy blockers, surfaces renal and hepatic dose adjustments, and suggests guideline-based alternatives, together, with cited sources. It is decision-support, not autonomous prescribing. Every flag is a prompt for you, and you verify against official sources and sign.